IOLCP
IOL Chemicals and Pharmaceuticals Limited
If management delivers what it guided
arithmetic on filed guidance and past valuations · not a price target
IOLCP
FY26 → FY27 · 1 year of guidance · ~0.7 years from today₹146 today
BEAR
₹45
-69%
8.7% a year · 8.8x exit
BASE
₹88
-40%
15% a year · 16.3x exit
BULL
₹100
-32%
20.4% a year · 17.6x exit
Where the market has priced it
3x31x today74x
- at 31x its FY26 earnings the stock already trades above the top of its own ten-year range (18x)
- the range is unusually wide — read it as the span of management's own claim, not as a forecast
How these numbers are produced
| Earnings base | FY26 fiscal year EPS ₹4.69 (screener) |
|---|---|
| Guided growth | 15% a year, said on the call of 18-Feb-2026 · transcript |
| Read across as | operating: revenue growth, margin held flat — medium confidence |
| Delivery calibration | 0.58x / 1x / 1.36x of what was guided — measured: 76 annual guided-vs-filed pairs + 77 near-complete quarterly years — NSE transcripts against the companies' own filings |
| Exit multiple | 8.85x / 16.3x / 17.64x, this company’s own p20 / median / p80 across 10 filed years |
| Filed-industry peers | median 23x across 40 peers — the cross-check, not the input |
| Arithmetic | base EPS × (1 + guided growth × delivery)1 × exit multiple |
Arithmetic on management’s own guidance and this company’s own past valuations. Not a price target, not a recommendation, and not a forecast of what the stock will do.
What management said
from NSE earnings-call filings · extracted, not interpreted
revenue growth 15%generic growth 10%
We had given a growth guidance of 10% to 15% revenue growth for FY '27.
Call 18-Feb-2026 · bridge confidence medium · transcript PDF